№ lp_1_2_20098
File format: docx
Character count: 8022
File size: 80 KB
Year:
2025
Region / City:
Humber and North Yorkshire
Topic:
Medicines and formulary recommendations
Document Type:
Recommendations summary
Author:
Medicines, Formulary, and Guidelines Group
Target Audience:
Healthcare professionals
Period of Validity:
Until December 2026
Approval Date:
19 November 2025
Date of Changes:
Not specified
Contextual description:
A source document summarizing the recommendations made by the Medicines, Formulary, and Guidelines Group regarding various drug formulary updates and changes for the Humber and North Yorkshire region.
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Date:
19 November 2025
Organization:
Medicines, Formulary, and Guidelines Group
Location:
Humber and North Yorkshire, UK
Document type:
Consultation summary / Recommendations
Drug:
MV140 Uromune Sublingual vaccine spray
Indication:
Recurrent lower urinary tract infections in adults
Formulary status:
Red – Specialist urology only
Treatment protocol:
2 sprays sublingually once daily for 3 months, possible rechallenge after 18 months
Cost per patient:
£297.50
Monitoring:
Telephone reviews at 1, 3, 6, 9, 12 months; Consultant Urologist review at 6 and 12 months
Professional target audience:
NHS healthcare professionals
Source:
HNY APC Professional Secretariat, Regional Drug and Therapeutics Centre
Year:
2025
Region:
Humber and North Yorkshire, UK
Subject:
Medicines formulary and NICE guidance recommendations
Document type:
Professional guidance / summary report
Organization:
Humber and North Yorkshire Area Prescribing Committee (HNY APC)
Author:
Medicines, Formulary, and Guidelines Group
Intended audience:
NHS healthcare professionals
Key drugs discussed:
Sildenafil, Darolutamide, Abiraterone, Cabotegravir
Decision criteria:
NICE technology appraisals, cost-effectiveness, commissioning status
Date of issue:
17 December 2025
Links:
https://humberandnorthyorkshire.org.uk/area-prescribing-committee-apc/apc-consultations/
Context:
Official NHS report summarizing formulary decisions, NICE appraisal outcomes, and local prescribing guidance for healthcare professionals.
Note:
Year
Region / City:
Moore County
Topic:
Land Use Planning, Agriculture, Rural Development
Document Type:
Draft Plan
Agency / Organization:
Moore County Planning Department
Target Audience:
Local residents, policymakers, urban planners
Date issued:
01 July 2024
Source:
ECO
Subject:
Clutter Digital Data for ITU-R P-Series Recommendations – information on Corine Land Cover (CLC) 2018 data and workflow
Type of report:
New Feature
SEAMCAT version:
5.5.1
SEAMCAT component involved:
PMP, Terrain Profile, Clutter Profile
Background information:
STG#82 discussed on digital terrain model and Clutter Digital Data for ITU-R P-Series Recommendations. Document STG(24)010 elaborates on this topic and outline possible options and free sources found so far.
Description of the issue:
There are only a few databases of DLU (land cover) data that are freely available for different parts of the world. The creation of these datasets is primarily driven by understanding the vegetation usage across the area and therefore the classifications for different types of buildings does vary significantly as does their resolution.
CLC Country coverage:
Fig: Map view of CLC land cover raster data
File format:
geoTIFF *.tif
Size:
242.18 MB
Extent:
900000.000,900000.000 : 7400000.000,5500000.000
Width:
65000
Height:
46000
Data type:
Byte - Eight bit unsigned integer
Dimensions:
X: 65000 Y: 46000
Bands:
1
Origin:
900000,5.5e+06
Pixel Size:
100,-100
Coordinate Resolution:
100 meters
Coordinate system name:
EPSG:3035 - ETRS89-extended / LAEA Europe
Coordinate Units:
meters
Projection Method:
Lambert Azimuthal Equal Area
Clutter category:
Representative clutter height (m)
Water/sea:
0
Open/rural:
0
Suburban:
10
Urban/trees/forest:
15
Dense urban:
20
Proposal:
Review the information provided on the appropriate data maps and decide how to move forward regarding PMPs using terrain.
Suggested Priority:
Medium
Documentation Recommendations to Assist with Adherence to the Peripheral Vestibular Hypofunction CPG
Year:
2023
Region / city:
N/A
Theme:
Vestibular rehabilitation
Document type:
Clinical guidelines
Author:
N/A
Target audience:
Healthcare professionals working with vestibular dysfunction
Period of validity:
N/A
Approval date:
N/A
Date of amendments:
N/A
Year:
2020
Region / City:
United States
Subject:
Public Health, Data Collection
Document Type:
Federal Register Notice
Agency:
Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS)
Author:
Centers for Disease Control and Prevention (CDC)
Target Audience:
General public, Federal agencies
Period of Validity:
N/A
Approval Date:
N/A
Date of Changes:
N/A
Year:
2026
Region / City:
Greater Manchester
Theme:
Healthcare, Pharmaceutical Recommendations
Document Type:
Report
Institution:
NHS Greater Manchester Medicines Management Group (GMMMG)
Author:
CRG (Clinical Reference Group)
Target Audience:
Healthcare professionals in the NHS
Period of validity:
Until 27th February 2026 (for specific drugs)
Approval Date:
13th January 2026
Date of Changes:
27th February 2026
Cost Impact:
£61,000 per year
Service Implications:
Transfer of prescribing to primary care, potential reduction in specialist service burden
Description:
Recommendations by the Clinical Reference Group (CRG) for the inclusion, continuation, or discontinuation of specific drugs, including azathioprine suspension and sotrovimab, in the Greater Manchester formulary.
Year:
2026
Region / city:
Nordic region
Topic:
TV Accessibility, Accessibility Services
Document Type:
Guidelines
Organization:
NorDig
Author:
NorDig
Target audience:
Manufacturers, broadcasters, distributors, and other stakeholders in the TV industry
Period of validity:
Ongoing
Approval date:
November 2025
Date of last revision:
Not specified
Year:
2023
Region / City:
Australia
Subject:
Drug-resistant tuberculosis management
Document Type:
Guidelines
Organization / Institution:
National Tuberculosis Advisory Committee
Author:
Richard Stapledon, Ellen Donnan
Target Audience:
Healthcare professionals
Period of Validity:
2023
Approval Date:
19/10/2023
Date of Changes:
Not specified
Date:
19 November 2025
Organization:
Medicines, Formulary, and Guidelines Group
Location:
Humber and North Yorkshire, UK
Document type:
Consultation summary / Recommendations
Drug:
MV140 Uromune Sublingual vaccine spray
Indication:
Recurrent lower urinary tract infections in adults
Formulary status:
Red – Specialist urology only
Treatment protocol:
2 sprays sublingually once daily for 3 months, possible rechallenge after 18 months
Cost per patient:
£297.50
Monitoring:
Telephone reviews at 1, 3, 6, 9, 12 months; Consultant Urologist review at 6 and 12 months
Professional target audience:
NHS healthcare professionals
Source:
HNY APC Professional Secretariat, Regional Drug and Therapeutics Centre
Year:
2018
Region / City:
Australia
Topic:
Education
Document Type:
Curriculum Guidelines
Author:
New South Wales Department of Education
Target Audience:
Teachers, Educators, Students (Stage 1)
Period of Action:
2018 and onward
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2024
Region / City:
Brazil
Subject:
Human Rights
Document Type:
Report
Organization:
Inter-American Commission on Human Rights (IACHR)
Author:
IACHR
Target Audience:
Governments, human rights organizations, international bodies
Effective Period:
2024
Approval Date:
2024
Date of Changes:
Not specified
Year:
2017
Region / City:
Washington, DC
Theme:
Public Health, Health IT, Zika Virus
Document Type:
Report
Organization / Institution:
Health IT Policy Committee (HITPC), Health IT Standards Committee (HITSC), Department of Health and Human Services
Author:
Public Health Task Force
Target Audience:
Public health professionals, health IT developers, clinicians
Period of Effectiveness:
2017
Approval Date:
March 8, 2017
Date of Changes:
Not specified
Year:
2024
Jurisdiction:
State of Washington
Document type:
Management Bulletin
Bulletin number:
H24-045
Issuing agency:
Department of Social and Health Services
Administration:
Aging and Long-Term Support Administration
Division:
Home and Community Services Division
Related agency:
Developmental Disabilities Administration
Authors:
Catherine Kinnaman; Jaime Bond
Date of issue:
July 31, 2024
Subject:
Electronic Visit Verification compliance
Programs referenced:
Medicaid; Electronic Visit Verification (EVV)
Legal basis:
21st Century Cures Act (2016)
Audience:
Contracted Home Care Agencies; Consumer Direct Care Network of Washington; Area Agency on Aging directors; HCS and DDA regional administrators
Geographic scope:
Washington State
Year:
2024
Region / city:
Global
Topic:
Oil Recovery Terminology
Document Type:
Report
Organization / Institution:
SPE (Society of Petroleum Engineers)
Authors:
D.D. Smith, S. Ayirala, B. Bai, P. Carreras, D. Hampton, K. Mohanty, W. Rossen, L. Schoeling, M. A. Yousef
Target Audience:
SPE Members, Oil Recovery Specialists
Period of Validity:
Ongoing
Approval Date:
2024
Date of Modifications:
Not specified
Year:
2023
Region / city:
Queensland
Subject:
Domestic and family violence reforms
Document type:
Government report
Organization / institution:
Queensland Government
Author:
Not specified
Target audience:
Non-government stakeholders, government officials
Period of validity:
2023-2025
Approval date:
Not specified
Date of changes:
Not specified
Note:
Year
Nature of the intervention:
Career Development
Target audience:
Practitioners involved in career guidance
Type of document:
Guidelines
Contextual description:
Guidelines outlining the criteria for quality assurance in career development interventions based on observation and self-reflection practices.
Year:
2026
Region / city:
United Kingdom
Topic:
Good Manufacturing Practice, Advanced Therapy Medicinal Products (ATMPs)
Document type:
Consultation response
Organization / institution:
NHS Advanced Therapy Medicinal Products Working Party
Author:
Anne Black
Target audience:
Pharmaceutical professionals, regulatory bodies, academic researchers
Period of validity:
Not specified
Approval date:
Not specified
Amendment date:
Not specified
Year:
2019
Region / City:
European Union
Topic:
PRIIPs Regulation amendments
Document Type:
Consultation Paper
Institution:
European Supervisory Authorities (ESAs)
Author:
European Supervisory Authorities (ESAs)
Target Audience:
Stakeholders in financial services and investments
Action Period:
16 October 2019 - 13 January 2020
Approval Date:
16 October 2019
Amendment Date:
Not specified
Year:
2026
Region / City:
Greater Manchester
Theme:
Healthcare, Pharmaceutical Recommendations
Document Type:
Report
Institution:
NHS Greater Manchester Medicines Management Group (GMMMG)
Author:
CRG (Clinical Reference Group)
Target Audience:
Healthcare professionals in the NHS
Period of validity:
Until 27th February 2026 (for specific drugs)
Approval Date:
13th January 2026
Date of Changes:
27th February 2026
Cost Impact:
£61,000 per year
Service Implications:
Transfer of prescribing to primary care, potential reduction in specialist service burden
Description:
Recommendations by the Clinical Reference Group (CRG) for the inclusion, continuation, or discontinuation of specific drugs, including azathioprine suspension and sotrovimab, in the Greater Manchester formulary.